Ben Ho

1.3k total citations
10 papers, 193 citations indexed

About

Ben Ho is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Genetics. According to data from OpenAlex, Ben Ho has authored 10 papers receiving a total of 193 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Pathology and Forensic Medicine and 4 papers in Genetics. Recurrent topics in Ben Ho's work include Chromatin Remodeling and Cancer (9 papers), Cancer Mechanisms and Therapy (5 papers) and Glioma Diagnosis and Treatment (4 papers). Ben Ho is often cited by papers focused on Chromatin Remodeling and Cancer (9 papers), Cancer Mechanisms and Therapy (5 papers) and Glioma Diagnosis and Treatment (4 papers). Ben Ho collaborates with scholars based in Canada, United States and Australia. Ben Ho's co-authors include Annie Huang, Michael C. Frühwald, Martin Hasselblatt, Franck Bourdeaut, Daniel Williamson, Yura Grabovska, Pascal D. Johann, Mamy Andrianteranagna, Fupan Yao and Marcel Kool and has published in prestigious journals such as Neuro-Oncology, Current Oncology Reports and Journal of Korean Neurosurgical Society.

In The Last Decade

Ben Ho

10 papers receiving 190 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ben Ho Canada 4 169 98 47 40 34 10 193
Kevin Ginn United States 6 143 0.8× 56 0.6× 70 1.5× 43 1.1× 39 1.1× 9 197
Felix Seyfried Germany 6 74 0.4× 23 0.2× 38 0.8× 45 1.1× 9 0.3× 16 145
Victor Enciso-Mora United Kingdom 4 51 0.3× 26 0.3× 38 0.8× 29 0.7× 4 0.1× 4 113
Agnieszka Budziłowska Poland 4 107 0.6× 78 0.8× 11 0.2× 8 0.2× 4 0.1× 6 132
Erika Launay France 4 18 0.1× 78 0.8× 35 0.7× 18 0.5× 20 0.6× 16 116
Naïs Prade France 5 35 0.2× 29 0.3× 37 0.8× 19 0.5× 4 0.1× 8 138
Mara Andrés Spain 4 17 0.1× 71 0.7× 43 0.9× 9 0.2× 23 0.7× 5 109
Illja J. Diets Netherlands 7 36 0.2× 44 0.4× 13 0.3× 6 0.1× 36 1.1× 8 113
Frédéric Davi France 4 41 0.2× 59 0.6× 39 0.8× 102 2.5× 5 0.1× 6 180
E. Feldman United States 6 53 0.3× 24 0.2× 48 1.0× 65 1.6× 8 0.2× 19 165

Countries citing papers authored by Ben Ho

Since Specialization
Citations

This map shows the geographic impact of Ben Ho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ben Ho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ben Ho more than expected).

Fields of papers citing papers by Ben Ho

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ben Ho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ben Ho. The network helps show where Ben Ho may publish in the future.

Co-authorship network of co-authors of Ben Ho

This figure shows the co-authorship network connecting the top 25 collaborators of Ben Ho. A scholar is included among the top collaborators of Ben Ho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ben Ho. Ben Ho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Mazewski, Claire, Sarah Leary, Guolian Kang, et al.. (2025). Phase 3 randomized trial of high-dose methotrexate for young children with high-risk embryonal brain tumors: A report from the Children’s Oncology Group. Neuro-Oncology. 27(10). 2726–2737. 3 indexed citations
2.
Golbourn, Brian, Ben Ho, Amanda Luck, et al.. (2024). A kinome drug screen identifies multi-TKI synergies and ERBB2 signaling as a therapeutic vulnerability in MYC/TYR subgroup atypical teratoid rhabdoid tumors. Neuro-Oncology. 26(10). 1895–1911. 2 indexed citations
3.
McDonald, Patrick J., Colin Kazina, Ben Ho, et al.. (2022). Sustained and durable response with Alisertib monotherapy in the treatment of relapsed Atypical Teratoid Rhabdoid Tumor (ATRT). Neuro-Oncology Advances. 4(1). vdac090–vdac090. 3 indexed citations
4.
Rubens, Jeffrey, Craig Erker, Ben Ho, et al.. (2022). Infantile suprasellar tumor diagnosed as a pineoblastoma RB1 subgroup and treatment challenges: A pediatric SNO Molecular Tumor Board. Neuro-Oncology Advances. 4(1). vdac092–vdac092. 1 indexed citations
6.
Li, Bryan, Peter C. Burger, Alexander R. Judkins, et al.. (2020). PATH-24. MOLECULAR CLASSIFICATION OF HIGH RISK INFANT EMBRYONAL BRAIN TUMORS ENROLLED IN THE ACNS0334 TRIAL: A REPORT FROM THE CHILDREN’S ONCOLOGY GROUP. Neuro-Oncology. 22(Supplement_3). iii429–iii429. 1 indexed citations
7.
Hoffman, Lindsey M., Elizabeth A. Richardson, Ben Ho, et al.. (2020). Advancing biology-based therapeutic approaches for atypical teratoid rhabdoid tumors. Neuro-Oncology. 22(7). 944–954. 25 indexed citations
8.
Ho, Ben, Pascal D. Johann, Yura Grabovska, et al.. (2019). Molecular subgrouping of atypical teratoid/rhabdoid tumors—a reinvestigation and current consensus. Neuro-Oncology. 22(5). 613–624. 120 indexed citations
9.
Sin‐Chan, Patrick, Bryan Li, Ben Ho, Adriana Fonseca, & Annie Huang. (2018). Molecular Classification and Management of Rare Pediatric Embryonal Brain Tumors. Current Oncology Reports. 20(9). 69–69. 12 indexed citations
10.
Richardson, Elizabeth A., Ben Ho, & Annie Huang. (2018). Atypical Teratoid Rhabdoid Tumour : From Tumours to Therapies. Journal of Korean Neurosurgical Society. 61(3). 302–311. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026